Gordonia sputi as an Arising Causative Agent of Bacteremia in Immunocompromised Comorbid Dialysis Patients-A Case Report

Improvements in medical care have turned severe diseases into chronic conditions, but often their treatment and the use of medical devices are related to specific complications. Here, we present a clinical case of a long-term dialysis patient who was infected with a rare opportunistic infectious agent-Gordonia sputi. In recent years, the incidence of Gordonia spp. infections in immunocompromised patients with central venous catheters (CVC) has appeared to rise. The isolation and identification of Gordonia spp. are challenging and require modern techniques. In addition, the treatment is usually persistent and often results in CVC extraction, which is associated with further risk and costs for the patient. We also studied the alterations in the immune status of the patient caused by long-term renal replacement therapy and persistent hepatitis C virus infection. Antibiotic therapy and immunostimulation with Inosine pranobex lead to successful eradication of the infection without the need for CVC replacement.

Automated summary

Improvements in medical care have transformed severe diseases into chronic conditions, but the treatment and use of medical devices often come with specific complications. This article presents a clinical case of a long-term dialysis patient who acquired a rare opportunistic infection called Gordonia sputi. In recent years, the incidence of Gordonia spp. infections has been increasing among immunocompromised patients with central venous catheters. Isolating and identifying Gordonia spp. is challenging and requires modern techniques. Treatment usually involves persistent therapy and may result in the extraction of the central venous catheter, posing additional risks and costs to the patient. Additionally, this study examines the effects of long-term renal replacement therapy and chronic hepatitis C virus infection on the patient's immune status. Successfully eradicating the infection was achieved through antibiotic therapy and immunostimulation with Inosine pranobex, eliminating the need for central venous catheter replacement.